HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Charles Deybach Selected Research

Ferrochelatase (Heme Synthetase)

1/2019Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria.
1/2015Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites.
4/2014Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.
10/2011Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model.
1/2007Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice.
1/2006Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria.
2/2004Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias.
1/2002The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Charles Deybach Research Topics

Disease

12Porphyrias (Porphyria)
11/2019 - 01/2002
10Erythropoietic Protoporphyria
01/2019 - 01/2002
8Acute Intermittent Porphyria (Porphyria, Acute)
11/2019 - 01/2002
4Hereditary Coproporphyria (Coproporphyrinogen Oxidase Deficiency)
11/2019 - 01/2002
3Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 08/2015
3Hepatic Porphyrias (Hepatic Porphyria)
11/2019 - 01/2002
3Variegate Porphyria (Protoporphyrinogen Oxidase Deficiency)
11/2019 - 02/2002
3Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
08/2011 - 02/2004
2Metabolic Diseases (Metabolic Disease)
01/2019 - 09/2015
2Hemochromatosis (Bronze Diabetes)
12/2013 - 02/2007
2Liver Failure
10/2011 - 09/2009
2X-linked sideroblastic anemia
06/2011 - 09/2008
2Schizophrenia (Dementia Praecox)
04/2010 - 03/2004
2Liver Diseases (Liver Disease)
09/2009 - 09/2008
1Chronic Renal Insufficiency
08/2015
1Pain (Aches)
07/2015
1Carcinoma (Carcinomatosis)
09/2013
1Phototoxic Dermatitis (Phototoxicity)
04/2013
1Erythema
04/2013
1Melanoma (Melanoma, Malignant)
04/2013
1Hepatocellular Carcinoma (Hepatoma)
01/2012
1Fibrosis (Cirrhosis)
10/2011
1Digestive System Diseases
10/2011
1Sclerosing Cholangitis
10/2011
1Cholestasis
10/2011
1Sideroblastic Anemia
06/2011
1Contact Dermatitis (Eczema, Contact)
09/2009
1Solar Urticaria
09/2009
1Cholelithiasis
09/2009
1Hydroa Vacciniforme
09/2009
1Acute Liver Failure (Fulminant Hepatic Failure)
09/2009
1Iron-Deficiency Anemia (Anemia, Iron Deficiency)
01/2007
1Hypochromic Anemia (Chlorosis)
01/2007
1Iron Deficiencies
01/2007
1Thrombophilia
06/2003
1Alcoholism (Alcohol Abuse)
11/2002
1Porphyria Cutanea Tarda
01/2002

Drug/Important Bio-Agent (IBA)

18Heme (Haem)IBA
01/2020 - 01/2002
8EnzymesIBA
01/2019 - 07/2004
8Ferrochelatase (Heme Synthetase)IBA
01/2019 - 01/2002
7Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
11/2019 - 01/2002
5protoporphyrin IXIBA
10/2011 - 06/2005
4Protoporphyrinogen Oxidase (Protox)IBA
11/2019 - 02/2002
4PorphyrinsIBA
09/2015 - 01/2002
3Acute Hepatic PorphyriaIBA
01/2020 - 10/2005
3Coproporphyrinogen Oxidase (Coproporphyrinogen III Oxidases)IBA
11/2019 - 01/2002
3IronIBA
06/2011 - 01/2007
3Dopamine Receptors (Dopamine Receptor)IBA
04/2010 - 11/2002
2Messenger RNA (mRNA)IBA
01/2019 - 01/2007
2Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2007
2PorphobilinogenIBA
09/2015 - 08/2015
2Aminolevulinic Acid (Levulan)FDA Link
09/2015 - 08/2015
2Hemochromatosis ProteinIBA
12/2013 - 02/2007
2Pharmaceutical PreparationsIBA
04/2013 - 09/2009
1Peptides (Polypeptides)IBA
01/2019
1LigandsIBA
01/2019
1Biological ProductsIBA
08/2015
1afamelanotideIBA
07/2015
1Melanocyte-Stimulating Hormones (MSH)IBA
07/2015
1Antisense OligonucleotidesIBA
04/2014
1VemurafenibIBA
04/2013
1Blood Group Antigens (Blood Groups)IBA
01/2012
1Bile Acids and Salts (Bile Acids)IBA
10/2011
1Indicators and Reagents (Reagents)IBA
10/2011
1Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
08/2011
15-Aminolevulinate SynthetaseIBA
08/2011
1zinc protoporphyrinIBA
09/2008
1Ceruloplasmin (Ferroxidase)IBA
02/2007
1Transferrin Receptors (Transferrin Receptor)IBA
01/2007
1Transferrin (beta 2 Transferrin)IBA
01/2007
1coproporphyrinogen IIIIBA
10/2005
1Oxidoreductases (Dehydrogenase)IBA
10/2005
1Phosphotransferases (Kinase)IBA
03/2004
1Factor V (Coagulation Factor V)IBA
06/2003
1Dopamine (Intropin)FDA LinkGeneric
11/2002
1Estrogens (Estrogen)FDA Link
01/2002

Therapy/Procedure

5Therapeutics
01/2019 - 02/2005
2Liver Transplantation
10/2011 - 07/2004
1Stem Cell Transplantation
02/2005
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2005